ProStrakan Group - M&A Summary and Business Overview

Life ScienceCompany

ProStrakan Group M&A Summary

ProStrakan Group has acquired 1 company. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.

ProStrakan Group’s largest acquisition to date was in 2014, when it acquired Archimedes Pharma for $354M. The Company’s most targeted sectors include life science (100%).

ProStrakan Group Business Overview

Where is ProStrakan Group headquartered?

ProStrakan Group is headquartered in Galashiels, United Kingdom.

What sector is ProStrakan Group in?

ProStrakan Group is a life science company.

When was ProStrakan Group founded?

ProStrakan Group was founded in 2004.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

ProStrakan Group Plc

Galabank Business Park,
Galashiels, TD1 1QH
United Kingdom,
44-0-1896-664000
www.prostrakan.com

ProStrakan Group plc was created in 2004 by the merger of Strakan Group plc and ProSkelia. The combined company, based in Galashiels, Scotland, is a rapidly growing international specialty pharmaceutical company engaged in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $354M $354M
Sell (0.0/yr) # 1 - - - - - 1
  2

Most Recent M&A

Company Date Value Type
Archimedes Pharma Ltd. 2014-08-06 354M GBP Add-on Acquisition
Reading, United Kingdom · www.archimedespharma.com
ProSkelia SASU 2006-12-22 - Divestiture
Paris, France
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 354M (100%) 1 (100%) -
Total 1 $354M 1 -

By Geo

State/Country Buy Value Sell Value
France - - 1 -
United Kingdom 1 354M - -
Domestic 1 (100%) 354M (100%) - -
Cross-border - - 1 (100%) -
Total 1 $354M 1 -

Deal Values

buy # Total
$100M to $1B 1 $354M
TOTAL $354M
Largest Archimedes Pharma Ltd.
$354M (2014-08-06)

M&A Connections

Deals
Acquired from
Investor(s)
100%
1 (100%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for ProStrakan Group

Life Science Companies , United Kingdom Companies